Publication | Open Access

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

Bone DiseaseBone HealthNew FracturesPost-menopausal WomenSevere OsteoporosisGynecologyMenopauseOsteoporosisMedicineOrthopaedic SurgeryWomen's Health